Femasys (FEMY) Cost of Revenue (2020 - 2026)

Femasys (FEMY) has reported Cost of Revenue for 7 consecutive years, with $142436.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 9.95% year-over-year to $142436.0; the trailing twelve-month figure through Jun 2026 stood at $610280.0 (down 7.35% YoY), and the FY2025 full-year result was $872400.0, up 60.1% from the prior year.
• Cost of Revenue eased to $142436.0 in Q2 2026 per FEMY's latest filing, from $158171.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $192407.0 in Q4 2024 and bottomed at $73125.0 in Q2 2024.
• Historically, Cost of Revenue has averaged $118985.5 across 5 years, with a median of $110469.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue slumped 34.43% in 2023, then soared 145.75% in 2024.
• Over 5 years, Cost of Revenue stood at $85459.0 in 2022, then slipped by 8.38% to $78294.0 in 2023, then surged by 145.75% to $192407.0 in 2024, then fell by 17.79% to $158171.0 in 2025, then decreased by 9.95% to $142436.0 in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $142436.0, $158171.0, and $117266.0 for Q2 2026, Q2 2025, and Q1 2025 respectively.